Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps (SINUS-52)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02898454
Recruitment Status : Completed
First Posted : September 13, 2016
Last Update Posted : November 26, 2018
Sponsor:
Collaborator:
Regeneron Pharmaceuticals
Information provided by (Responsible Party):
Sanofi

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 27, 2018
  Actual Study Completion Date : November 16, 2018